<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023177/" ref="ordinalpos=228&amp;ncbi_uid=6142458&amp;link_uid=PMC4023177" image-link="/pmc/articles/PMC4023177/figure/F3/" class="imagepopup">Figure 3.  From: Quantitative proteomics analysis of early recurrence/metastasis of huge hepatocellular carcinoma following radical resection. </a></div><br /><div class="p4l_captionBody"><b>The key signaling pathways involved in the early recurrence/metastasis (R/M</b><b>≤6months</b><b>) and late recurrence/metastasis (R/M</b><b>6-12months</b><b>) of H-HCC. (A)</b> The alternations of the ERK1/2 signaling pathway in the R/M≤6months group, including 6 up-regulated proteins (red labeling) and 7 down-regulated (green labeling) proteins. <b>(B)</b> The alternations of the TNF signaling pathway in the R/M≤6months group, including 4 up-regulated proteins (red labeling) and 9 down-regulated proteins (green labeling). <b>(C)</b> The alternations of the TNF signaling pathway in the R/M6-12months group, including 7 up-regulated proteins (red labeling) and 5 down-regulated proteins (green labeling). <b>(D)</b> the alternations of the NFκB signaling pathway in the R/M6-12months group, including 9 up-regulated proteins (red labeling) and 2 down-regulated (green labeling) proteins.</div></div>